AFLD 2012 FFC vs Respondent M81

Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M81 for a violation of the Anti-Doping Rules. During a match on March 6, 2012, a sample was taken for doping test purposes. The sample tested positive on the prohibited substance 19-norandostrone. 19-norandostrone is a prohibited substance according the World Anti-Doping Agency prohibited list.

History
The respondent admitted that he injected the norandostrone intramuscularly, in order to improve his physical condition. Because of personal problems which lead to deterioration of his psychological state, for which he was hospitalized, made him using the prohibited substance. He has medical prescriptions to prove this.

Decision
1. The sanction is a period of ineligibility of two years in which the respondent can't take part in competition or manifestations organized by the French sport federations.
2. The present decision shall take effect from the date of notification
sent to the respondent. It will apply until the end of the sanction dated May 15, 2012 by the disciplinary committee of the FFC.
3. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
11 January 2012
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Cyclisme (FFC) - French Cycling Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S1. Anabolic Agents
Substances
19-norandrosterone
Medical terms
Treatment / self-medication
Document type
Pdf file
Date generated
26 February 2014
Date of last modification
12 March 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin